Michael L. Sabolinski

4.8k total citations · 2 hit papers
40 papers, 3.3k citations indexed

About

Michael L. Sabolinski is a scholar working on Rehabilitation, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Michael L. Sabolinski has authored 40 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Rehabilitation, 16 papers in Cardiology and Cardiovascular Medicine and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Michael L. Sabolinski's work include Wound Healing and Treatments (21 papers), Heart Failure Treatment and Management (16 papers) and Pressure Ulcer Prevention and Management (11 papers). Michael L. Sabolinski is often cited by papers focused on Wound Healing and Treatments (21 papers), Heart Failure Treatment and Management (16 papers) and Pressure Ulcer Prevention and Management (11 papers). Michael L. Sabolinski collaborates with scholars based in United States, Brazil and Poland. Michael L. Sabolinski's co-authors include Vincent Falanga, Manuel Worcel, Jay N. Cohn, Anne L. Taylor, Kirkwood F. Adams, David G. Armstrong, Aristidis Veves, Clyde W. Yancy, Susan Ziesche and Keith C. Ferdinand and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Michael L. Sabolinski

38 papers receiving 3.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure

2004 1.1k citations Anne L. Taylor, Susan Ziesche et al. New England Journal of Medicine profile →
Graftskin, a Human Skin Equivalent, Is Effective in the Management of Noninfected Neuropathic Diabetic Foot Ulcers

2001 567 citations Michael L. Sabolinski et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael L. Sabolinski United States	22	1.3k	1.2k	778	710	444	40	3.3k
Paula K. Shireman United States	28	512 0.4×	288 0.2×	232 0.3×	890 1.3×	45 0.1×	93	2.8k
Frances L. Game United Kingdom	44	3.7k 2.9×	183 0.1×	4.9k 6.3×	1.3k 1.9×	2.2k 4.9×	137	6.0k
Rachael O. Forsythe United Kingdom	22	441 0.3×	253 0.2×	728 0.9×	673 0.9×	285 0.6×	58	1.8k
Mark D. Iafrati United States	30	146 0.1×	312 0.3×	473 0.6×	1.7k 2.4×	78 0.2×	102	3.9k
Janice Tsui United Kingdom	25	219 0.2×	454 0.4×	137 0.2×	786 1.1×	46 0.1×	98	2.0k
Kuo‐Chun Hung Taiwan	22	293 0.2×	521 0.4×	195 0.3×	406 0.6×	25 0.1×	108	1.7k
Andrew Stanley United States	22	307 0.2×	445 0.4×	178 0.2×	693 1.0×	96 0.2×	53	1.9k
Enrico Brocco Italy	25	367 0.3×	518 0.4×	1.1k 1.4×	548 0.8×	138 0.3×	62	2.4k
Marc Mitchell United States	22	239 0.2×	511 0.4×	146 0.2×	752 1.1×	40 0.1×	62	2.1k
Michael Belkin United States	42	138 0.1×	1.4k 1.1×	443 0.6×	3.9k 5.4×	42 0.1×	175	6.0k

Countries citing papers authored by Michael L. Sabolinski

Since Specialization

Citations

This map shows the geographic impact of Michael L. Sabolinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Sabolinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Sabolinski more than expected).

Fields of papers citing papers by Michael L. Sabolinski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael L. Sabolinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Sabolinski. The network helps show where Michael L. Sabolinski may publish in the future.

Co-authorship network of co-authors of Michael L. Sabolinski

This figure shows the co-authorship network connecting the top 25 collaborators of Michael L. Sabolinski. A scholar is included among the top collaborators of Michael L. Sabolinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael L. Sabolinski. Michael L. Sabolinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cazzell, Shawn, et al.. (2024). Dehydrated Amnion Chorion Membrane versus standard of care for diabetic foot ulcers: a randomised controlled trial. Journal of Wound Care. 33(Sup7). S4–S14. 3 indexed citations

Sabolinski, Michael L., et al.. (2019). Comparative effectiveness of a human fibroblast-derived dermal substitute and a viable cryopreserved placental membrane for the treatment of diabetic foot ulcers. Journal of Comparative Effectiveness Research. 8(14). 1229–1238. 9 indexed citations

Sabolinski, Michael L.. (2018). Comparative Effectiveness of a Bilayered Living Cellular Construct and an Acellular Fetal Bovine Collagen Dressing in the Treatment of Venous Leg Ulcers. Value in Health. 21. S162–S162. 1 indexed citations

Sabolinski, Michael L., et al.. (2017). The Comparative Effectiveness of a Human Fibroblast Dermal Substitute versus a Dehydrated Human Amnion/Chorion Membrane Allograft for the Treatment of Diabetic Foot Ulcers in a Real-world Setting.. PubMed. 29(5). 125–132. 6 indexed citations

Treadwell, Terry, Michael L. Sabolinski, Michelle Skornicki, & Nathan B. Parsons. (2017). Comparative Effectiveness of a Bioengineered Living Cellular Construct and Cryopreserved Cadaveric Skin Allograft for the Treatment of Venous Leg Ulcers in a Real-World Setting. Advances in Wound Care. 7(3). 69–76. 6 indexed citations

Sabolinski, Michael L., S. William Tam, Susan Ziesche, et al.. (2012). Effect of Fixed-Dose Combined Isosorbide Dinitrate/Hydralazine in Elderly Patients in the African-American Heart Failure Trial. Journal of Cardiac Failure. 18(8). 600–606. 11 indexed citations

Ghali, Jalal K., S. William Tam, Michael L. Sabolinski, et al.. (2008). Exploring the Potential Synergistic Action of Spironolactone on Nitric Oxide–Enhancing Therapy: Insights From the African-American Heart Failure Trial. Journal of Cardiac Failure. 14(9). 718–723. 8 indexed citations

Ghali, Jalal K., S. William Tam, Keith C. Ferdinand, et al.. (2007). Effects of ACE Inhibitors or β-Blockers in Patients Treated with the Fixed-Dose Combination of Isosorbide Dinitrate/Hydralazine in the African-American Heart Failure Trial. American Journal of Cardiovascular Drugs. 7(5). 373–380. 12 indexed citations

Tam, S. William, Michael L. Sabolinski, Manuel Worcel, Milton Packer, & Jay N. Cohn. (2007). Lack of Bioequivalence between Different Formulations of Isosorbide??Dinitrate and Hydralazine and??the??Fixed-Dose Combination of??Isosorbide Dinitrate/Hydralazine. Clinical Pharmacokinetics. 46(10). 885–895. 14 indexed citations

10.

Yancy, Clyde W., Jalal K. Ghali, Virginia Braman, et al.. (2007). Evidence for the Continued Safety and Tolerability of Fixed-Dose Isosorbide Dinitrate/Hydralazine in Patients With Chronic Heart Failure (the Extension to African-American Heart Failure Trial). The American Journal of Cardiology. 100(4). 684–689. 7 indexed citations

11.

McNamara, Dennis M., S. William Tam, Michael L. Sabolinski, et al.. (2006). Aldosterone Synthase Promoter Polymorphism Predicts Outcome in African Americans With Heart Failure. Journal of the American College of Cardiology. 48(6). 1277–1282. 69 indexed citations

12.

Taylor, Anne L., JoAnn Lindenfeld, Susan Ziesche, et al.. (2006). Outcomes by Gender in the African-American Heart Failure Trial. Journal of the American College of Cardiology. 48(11). 2263–2267. 42 indexed citations

13.

Yancy, Clyde W., Jalal K. Ghali, Virginia Braman, Michael L. Sabolinski, & Manuel Worcel. (2006). Results of the Extension to A-HeFT [X-A-HeFT] Support the Continued Safety and Tolerability of Fixed-Dose Isosorbide Dinitrate/Hydralazine (ISDN/HYD). Journal of Cardiac Failure. 12(6). S80–S80. 2 indexed citations

14.

Anand, Inder S., S. William Tam, Thomas S. Rector, et al.. (2006). Influence of Blood Pressure on the Effectiveness of a Fixed-Dose Combination of Isosorbide Dinitrate and Hydralazine in the African-American Heart Failure Trial. Journal of the American College of Cardiology. 49(1). 32–39. 47 indexed citations

15.

Taylor, Anne L., Susan Ziesche, Clyde W. Yancy, et al.. (2004). Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure. New England Journal of Medicine. 351(20). 2049–2057. 1105 indexed citations breakdown →

16.

Kerstein, Morris D., et al.. (2002). Development of a Severity Scale for Evaluating the Need for Graftskin in Nonhealing Venous Ulcers. Advances in Skin & Wound Care. 15(2). 66–71. 11 indexed citations

17.

Kirsner, Robert S., et al.. (1999). Behavior of Tissue-Engineered Skin. Archives of Dermatology. 135(8). 913–8. 73 indexed citations

18.

Sabolinski, Michael L., Oscar M. Alvarez, Michael J. Auletta, Gerit Mulder, & Nancy L. Parenteau. (1996). Cultured skin as a ‘smart material’ for healing wounds: experience in venous ulcers. Biomaterials. 17(3). 311–320. 163 indexed citations

19.

Parenteau, Nancy L., et al.. (1996). Biological and physical factors influencing the successful engraftment of a cultured human skin substitute. Biotechnology and Bioengineering. 52(1). 3–14. 26 indexed citations

20.

Bystryn, Jean‐Claude & Michael L. Sabolinski. (1986). Effect of substrate on indirect immunofluorescence tests for intercellular and basement membrane zone antibodies. Journal of the American Academy of Dermatology. 15(5). 973–977. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact